VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 07/17/2024 at 22:00, 1 year 4 months ago

Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la vaccination primaire de tous les participants
Pfizer et Valneva finalisent la vaccination primaire de l'essai de Phase 3 VALOR contre la maladie de Lyme, avec VLA15. Suivi des participants pour mesurer l'incidence de la maladie

Valneva Maladie De Lyme Pfizer Phase 3 VALOR Vaccination Primaire
PRESS RELEASE

published on 07/17/2024 at 22:00, 1 year 4 months ago

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion
Phase 3 VALOR Lyme Disease Trial: Pfizer and Valneva announce completion of primary vaccination series with VLA15, progressing towards a Lyme disease vaccine

Valneva Lyme Disease Vaccine Pfizer VLA15 VALOR
BRIEF

published on 06/05/2024 at 07:05, 1 year 6 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Executive Changes Corporate Update Valneva Shareholder Meeting
BRIEF

published on 06/05/2024 at 07:05, 1 year 6 months ago

Valneva annonce la mise à disposition de la documentation pour son Assemblée Générale Mixte et fait le point sur l'entreprise

Assemblée Générale Valneva Mise À Jour De L'entreprise Changements À La Direction
PRESS RELEASE

published on 06/05/2024 at 07:00, 1 year 6 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor

Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
PRESS RELEASE

published on 06/05/2024 at 07:00, 1 year 6 months ago

Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction

Documents Préparatoires Valneva Assemblée Générale Mixte Équipe De Direction Kendra Wergin
BRIEF

published on 05/21/2024 at 07:05, 1 year 6 months ago

Valneva nomme le Dr Hanneke Schuitemaker comme Directeur Scientifique

Nomination R&D Valneva Dr Hanneke Schuitemaker Vaccins
BRIEF

published on 05/21/2024 at 07:05, 1 year 6 months ago

Valneva appoints Dr Hanneke Schuitemaker as Scientific Director

Nomination R&D Valneva Vaccines Dr Hanneke Schuitemaker
PRESS RELEASE

published on 05/21/2024 at 07:00, 1 year 6 months ago

Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique
Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique, renforçant ainsi son équipe de direction. Le Dr Schuitemaker apportera son expertise en R&D pour développer des solutions vaccinales innovantes

R&D Valneva Dr Hanneke Schuitemaker Vaccins Directeur Scientifique
PRESS RELEASE

published on 04/18/2024 at 16:01, 1 year 7 months ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research bestätigt Kaufempfehlung für Valneva SE mit Kursziel von €8,60 nach positiven Ergebnissen und Schuldenerlass. Analyse von Analyst Simon Scholes, CFA

Research Update Kaufempfehlung Valneva Simon Scholes Schuldenerlass

Accesswire

Published on 12/05/2025 at 17:15, 14 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 29 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 29 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 44 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 44 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 29 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 4 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 19 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 29 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 29 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 11 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 11 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 18 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 18 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 31 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE